Carole Mitnick

14PUBLICATIONS
74CO-AUTHORS
PharmacogenomicsBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillancePharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 24, 2026
Clofazimine pharmacokinetics in novel rifampicin-resistant tuberculosis regimens: an analysis of the endTB and endTB-Q trials.

|Feb 02, 2026
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence.

Allison LaHood, James Robins, Helen R Stagg

|Jan 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.

Lorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez

|Dec 10, 2024
The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.

Uzma Khan, Michael Rich, Molly F Franke

|Jul 25, 2022
Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different.

Allison LaHood, Rifat Rahman, Lindsay McKenna

|Sep 26, 2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.

L Guglielmetti, E Ardizzoni, M Atger

Pageof 3

Frequent Collaborators

3 joint publications

Kwonjune J Seung

3 joint publications

Payam Nahid

3 joint publications

Uzma Khan

3 joint publications

Allison N LaHood